Manufacturing Engineer

, and 6 assembly lines. We are committed to creating a dynamic work environment where talent thrives, and bold ideas...

Lugar: Monterrey, N.L. | 29/11/2025 01:11:51 AM | Salario: S/. No Especificado | Empresa: Polaris

Payroll Specialist

ideas and connect the dots to build a better and bold new future. We are looking for your talent...

Lugar: Guadalajara, Jal. | 29/11/2025 01:11:51 AM | Salario: S/. No Especificado | Empresa: Wipro

Digital Presales Solution Architect

are valued and succeed here. We have the flexibility to manage our work and personal needs. We make bold moves, together... bold moves, together, and are a force for good. Let's Stay Connected: Follow on Instagram to see the latest on people...

Lugar: Ciudad de México | 28/11/2025 20:11:45 PM | Salario: S/. No Especificado | Empresa: Hewlett Packard Enterprise

Payroll Specialist

ideas and connect the dots to build a better and bold new future. We are looking for your talent...

Lugar: Guadalajara, Jal. | 28/11/2025 02:11:09 AM | Salario: S/. No Especificado | Empresa: Wipro

HR Administrator

ideas and connect the dots to build a better and bold new future. We are looking for your talent...

Lugar: Guadalajara, Jal. | 27/11/2025 20:11:56 PM | Salario: S/. No Especificado | Empresa: Wipro

Legal Director Mexico

perspective and helps others do the same. A people leader who raises the bar for their team, develops talent, and fosters trust...'s mission is to reimagine the way the world moves for the better. Here, bold ideas create real-world impact, challenges drive...

Lugar: Ciudad de México | 23/11/2025 18:11:21 PM | Salario: S/. No Especificado | Empresa: Uber

Specialty Market Access Manager

GSK remains committed to achieving bold commercial ambitions for the future. By 2031, we aim to deliver £40 billion... to achieving bold commercial ambitions for the future. By 2031, we aim to deliver £40 billion in annual sales, leveraging...

Lugar: Ciudad de México | 22/11/2025 23:11:57 PM | Salario: S/. No Especificado | Empresa: GlaxoSmithKline